Physician Factors Associated with Polypharmacy and Potentially Inappropriate Medication Use

References

1. 1.↵
   1. Fulton MM,
   2. Allen ER

   . Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005;17:123–32.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Zarowitz BJ,
   2. Stebelsky LA,
   3. Muma BK,
   4. Romain TM,
   5. Peterson EL

   . Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting Pharmacotherapy 2005;25:1636–45.
3. 3.↵
   1. Viktil KK,
   2. Blix HS,
   3. Moger TA,
   4. Reikvam A

   . Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007;63:187–95.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Charlesworth CJ,
   2. Smit E,
   3. Lee DS,
   4. Alramadhan F,
   5. Odden MC

   . Polypharmacy among adults aged 65 years and older in the united states: 1988–2010. J Gerontol A Biol Sci Med Sci. 2015;70:989–95.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Goulding MR

   . Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004;164:305–12.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015;63:2227–46.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Gyllensten H,
   2. Rehnberg C,
   3. Jönsson AK,
   4. Petzold M,
   5. Carlsten A,
   6. Andersson Sundell K

   . Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey. BMJ Open 2013;3:1–12.

   OpenUrlCrossRef
8. 8.↵
   NHE fact sheet. Baltimore: Centers for Medicare and Medicaid Services; 2015. Available from: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html. Accessed June 7, 2017.
9. 9.↵
   1. Veehof L,
   2. Stewart R,
   3. Haaijer-Ruskamp F,
   4. Jong BM

   . The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261–7.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Peterson L,
    2. Bazemore AW,
    3. Phillips RL Jr.,
    4. et al

    . Family physicians' present and future role in caring for older patients. Am Fam Physician 2009;80:1072.

    OpenUrlPubMed
11. 11.↵
    1. Buck MD,
    2. Atreja A,
    3. Brunker CP,
    4. et al

    . Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records. Am J Geriatr Pharmacother 2009;7:84–92.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Payne RA,
    2. Avery AJ,
    3. Duerden M,
    4. Saunders CL,
    5. Simpson CR,
    6. Abel GA

    . Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol 2014;70:575–81.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Junius-Walker U,
    2. Theile G,
    3. Hummers-Pradier E

    . Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007;24:14–9.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Thompson W,
    2. Farrell B

    . Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm 2013;66:201–2.

    OpenUrlPubMed
15. 15.↵
    1. Reeve E,
    2. Shakib S,
    3. Hendrix I,
    4. Roberts MS,
    5. Wiese MD

    . The benefits and harms of deprescribing. Med J Aust 2014;201:9–12.

    OpenUrl
16. 16.↵
    1. Iyer S,
    2. Naganathan V,
    3. McLachlan AJ,
    4. Le Couteur DG

    . Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008;25:1021–31.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Patterson S,
    2. Cadogan C,
    3. Kerse N,
    4. et al

    . Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014;(10):CD008165.
18. 18.↵
    1. Schuling J,
    2. Gebben H,
    3. Veehof LJG,
    4. Haaijer-Ruskamp FM

    . Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract 2012;13:56.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Magin P,
    2. Goode S,
    3. Pond D

    . GPs, medications and older people: a qualitative study of general practitioners' approaches to potentially inappropriate medications in older people. Australas J Ageing 2014;34:e134–9.

    OpenUrl
20. 20.↵
    1. Ní Chróinín D,
    2. Ní Chróinín C,
    3. Beveridge A

    . Factors influencing deprescribing habits among geriatricians. Age Ageing 2015;44:704–8.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. O'Mahony D,
    2. O'Sullivan D,
    3. Byrne S,
    4. O'Connor MN,
    5. Ryan C,
    6. Gallagher P

    . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015;44:213–8.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    QuickFacts: United States. Washington, DC: US Census Bureau; 2015. Available from: https://www.census.gov/quickfacts/table/PST045215/00. Accessed November 22, 2016.
23. 23.↵
    1. Jirón M,
    2. Pate V,
    3. Hanson LC,
    4. Lund JL,
    5. Jonsson Funk M,
    6. Stürmer T

    . Trends in prevalence and determinants of potentially inappropriate prescribing in the united states: 2007 to 2012. J Am Geriatr Soc 2016;64:788–97.

    OpenUrl
24. 24.↵
    1. Alhmoud E,
    2. Khalifa S,
    3. Bahi AA

    . Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm 2015;37:815–21.

    OpenUrl
25. 25.↵
    1. San-José A,
    2. Agustí A,
    3. Vidal X,
    4. et al

    . Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr 2015;15:42.

    OpenUrl
26. 26.↵
    1. Voigt K,
    2. Gottschall M,
    3. Köberlein-Neu J,
    4. et al

    . Why do family doctors prescribe potentially inappropriate medication to elderly patients? BMC Fam Pract 2016;17:93.

    OpenUrl
27. 27.↵
    1. Sackett DL,
    2. Rosenberg WC,
    3. Gray JA,
    4. Haynes RB,
    5. Richardson WS

    . Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71–2.

    OpenUrlFREE Full Text
28. 28.↵
    1. Smedley BD,
    2. Stith AY,
    3. Nelson AR

    , eds; Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care. Washington DC: National Academies Press; 2003.
29. 29.↵
    1. Duran-Tauleria E,
    2. Rona RJ,
    3. Chinn S,
    4. Burney P

    . Influence of ethnic group on asthma treatment in children in 1990–1: national cross sectional study. BMJ 1996;313:148–52.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Ryall AH,
    2. Abdulah DR,
    3. Rios D,
    4. Wei JY,
    5. Hausdorff JM

    . Undertreatment of cardiovascular disease in ethnically diverse older adults: who should receive an electrocardiogram? J Am Geriatr Soc 2001;49:1573–4.

    OpenUrlPubMed